RankingsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Income before tax

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥188.4B
P/E ratio
67.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 202521,279+113.84%
Mar 31, 20249,951+14.03%
Mar 31, 20238,727-50.25%
Mar 31, 202217,542-3.73%
Mar 31, 202118,222-32.38%
Mar 31, 202026,946+7.90%
Mar 31, 201924,972-10.35%
Mar 31, 201827,854-10.09%
Mar 31, 201730,981-12.40%
Mar 31, 201635,365+73.41%
Mar 31, 201520,394+31.40%
Mar 31, 201415,521+8.92%
Mar 31, 201314,250-3.74%
Mar 31, 201214,803

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)